Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Leussink, BT; Slikkerveer, A; Engelbrecht, MRW; van der Voet, GB; Nouwen, EJ; de Heer, E; de Broe, ME; de Wolff, FA; Bruijn, JA
   Bismuth overdosing-induced reversible nephropathy in rats
   ARCHIVES OF TOXICOLOGY
   
   B.T. Leussink et al., "Bismuth overdosing-induced reversible nephropathy in rats", ARCH TOXIC, 74(12), 2001, pp. 745-754
2. Leussink, BT; Litvinov, SV; de Heer, E; Slikkerveer, A; van der Voet, GB; Bruijn, JA; de Wolff, FA
   Loss of homotypic epithelial cell adhesion by selective N-cadherin displacement in bismuth nephrotoxicity
   TOXICOLOGY AND APPLIED PHARMACOLOGY
   
   B.T. Leussink et al., "Loss of homotypic epithelial cell adhesion by selective N-cadherin displacement in bismuth nephrotoxicity", TOX APPL PH, 175(1), 2001, pp. 54-59
3. 
   Anti-ulcer agents: indications in adult patients. Recommendations for goodpractice
   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
   
   GASTRO CL B, 24(4), 2000, pp. 447-460
4. Leussink, BT; Slikkerveer, A; Krauwinkel, WJJ; van der Voet, GB; de Heer, E; de Wolff, FA; Bruijn, JA
   Bismuth biokinetics and kidney histopathology after bismuth overdose in rats
   ARCHIVES OF TOXICOLOGY
   
   B.T. Leussink et al., "Bismuth biokinetics and kidney histopathology after bismuth overdose in rats", ARCH TOXIC, 74(7), 2000, pp. 349-355
5. Miwa, H; Hirai, S; Nagahara, A; Murai, T; Nishira, T; Kikuchi, S; Takei, Y; Watanabe, S; Sato, N
   Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients - a double-blind placebo-controlled study
   ALIMENTARY PHARMACOLOGY & THERAPEUTICS
   
   H. Miwa et al., "Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients - a double-blind placebo-controlled study", ALIM PHARM, 14(3), 2000, pp. 317-324
6. Oderda, G; Rapa, A; Bona, G
   A systematic review of Helicobacter pylori eradication treatment schedulesin children
   ALIMENTARY PHARMACOLOGY & THERAPEUTICS
   
   G. Oderda et al., "A systematic review of Helicobacter pylori eradication treatment schedulesin children", ALIM PHARM, 14, 2000, pp. 59-66
7. Dore, MP; Leandro, G; Realdi, G; Sepulveda, AR; Graham, DY
   Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy - A meta-analytical approach
   DIGESTIVE DISEASES AND SCIENCES
   
   M.P. Dore et al., "Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy - A meta-analytical approach", DIG DIS SCI, 45(1), 2000, pp. 68-76
8. Danesh, J; Lawrence, M; Murphy, M; Roberts, S; Collins, R
   Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia
   ARCHIVES OF INTERNAL MEDICINE
   
   J. Danesh et al., "Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia", ARCH IN MED, 160(8), 2000, pp. 1192-1198
9. 
   Anti-ulcer agents: indications in adults
   ANNALES DE MEDECINE INTERNE
   
   ANN MED IN, 151(5), 2000, pp. 353-368
10. Talley, NJ; Janssens, J; Lauritsen, K; Racz, I; Bolling-Sternevald, E
    Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up
    BRITISH MEDICAL JOURNAL
    
    N.J. Talley et al., "Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up", BR MED J, 318(7187), 1999, pp. 833-837
11. Dhali, GK; Garg, PK; Sharma, MP
    Role of anti-Helicobacter pylori treatment in H-Pylori-positive and cytoprotective drugs in H-Pylori-negative, non-ulcer dyspepsia: Results of a randomized, double-blind, controlled trial in Asian Indians
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    
    G.K. Dhali et al., "Role of anti-Helicobacter pylori treatment in H-Pylori-positive and cytoprotective drugs in H-Pylori-negative, non-ulcer dyspepsia: Results of a randomized, double-blind, controlled trial in Asian Indians", J GASTR HEP, 14(6), 1999, pp. 523-528
12. Buring, SM; Winner, LH; Hatton, RC; Doering, PL
    Discontinuation rates of Helicobacter pylori treatment regimens: A meta-analysis
    PHARMACOTHERAPY
    
    S.M. Buring et al., "Discontinuation rates of Helicobacter pylori treatment regimens: A meta-analysis", PHARMACOTHE, 19(3), 1999, pp. 324-332
13. Catalano, F; Branciforte, G; Brogna, A; Bentivegna, C; Luca, S; Terranova, R; Michalos, A; Dawson, BK; Chodash, HB
    Helicobacter pylori-positive functional dyspepsia in elderly patients - Comparison of two treatments
    DIGESTIVE DISEASES AND SCIENCES
    
    F. Catalano et al., "Helicobacter pylori-positive functional dyspepsia in elderly patients - Comparison of two treatments", DIG DIS SCI, 44(5), 1999, pp. 863-867
14. Unge, P
    Antibiotic treatment of Helicobacter pylori infection
    GASTRODUODENAL DISEASE AND HELICOBACTER PYLORI
    
    P. Unge, "Antibiotic treatment of Helicobacter pylori infection", CURR T MICR, 241, 1999, pp. 261-300
15. Sandha, GS; Hunt, RH; van Zanten, SJOV
    A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and -negative non-ulcer dyspepsia
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    
    G.S. Sandha et al., "A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and -negative non-ulcer dyspepsia", SC J GASTR, 34(3), 1999, pp. 244-249
16. Xia, HHX; Talley, NJ
    Helicobacter pylori eradication in patients with non-ulcer dyspepsia
    DRUGS
    
    H.H.X. Xia e N.J. Talley, "Helicobacter pylori eradication in patients with non-ulcer dyspepsia", DRUGS, 58(5), 1999, pp. 785-792
17. Aal, GMA; Dajani, AI; Nounou, M; Awad, S; Rasheed, ZA; Gautam, S; Ukabam, S; Nayal, S
    Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week
    DIGESTION
    
    G.M.A. Aal et al., "Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week", DIGESTION, 60(3), 1999, pp. 286-297
18. Yamamoto, Y; Hakki, A; Friedman, H; Okubo, S; Shimamura, T; Hoffman, PS; Rossignol, JF
    Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity
    CHEMOTHERAPY
    
    Y. Yamamoto et al., "Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity", CHEMOTHERA, 45(4), 1999, pp. 303-312
19. Greenberg, PD; Cello, JP
    Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia
    ARCHIVES OF INTERNAL MEDICINE
    
    P.D. Greenberg e J.P. Cello, "Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia", ARCH IN MED, 159(19), 1999, pp. 2283-2288
20. Mearin, F; Balboa, A; Zarate, N; Cucala, M; Malagelada, JR
    Placebo in functional dyspepsia: Symptomatic, gastrointestinal motor, and gastric sensorial responses
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    F. Mearin et al., "Placebo in functional dyspepsia: Symptomatic, gastrointestinal motor, and gastric sensorial responses", AM J GASTRO, 94(1), 1999, pp. 116-125
21. GISBERT JP; BOIXEDA D; DEARGILA CM; PLAZA AG
    HELICOBACTER-PYLORI AND NONULCER DYSPEPSI A - A MATTER PENDING
    Revista espanola de enfermedades digestivas
    
    J.P. Gisbert et al., "HELICOBACTER-PYLORI AND NONULCER DYSPEPSI A - A MATTER PENDING", Revista espanola de enfermedades digestivas, 90(6), 1998, pp. 441-453
22. Pantoflickova, D; Blum, AL; Koelz, HR
    Helicobacter pylori and functional dyspepsia: a real causal link?
    BAILLIERES CLINICAL GASTROENTEROLOGY
    
    D. Pantoflickova et al., "Helicobacter pylori and functional dyspepsia: a real causal link?", BAIL CLIN G, 12(3), 1998, pp. 503-532
23. Unge, P
    Are there more clinically important complications of Helicobacter pylori infection than peptic ulcer disease? A review of current literature
    JOURNAL OF GASTROENTEROLOGY
    
    P. Unge, "Are there more clinically important complications of Helicobacter pylori infection than peptic ulcer disease? A review of current literature", J GASTRO, 33, 1998, pp. 48-52
24. LU CL; CHANG FY; CHEN TS; CHEN CY; JIUN KL; LEE SD
    HELICOBACTER-PYLORI COLONIZATION DOES NOT INFLUENCE THE SYMPTOMATIC RESPONSE TO PROKINETIC AGENTS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA
    Journal of gastroenterology and hepatology
    
    C.L. Lu et al., "HELICOBACTER-PYLORI COLONIZATION DOES NOT INFLUENCE THE SYMPTOMATIC RESPONSE TO PROKINETIC AGENTS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA", Journal of gastroenterology and hepatology, 13(5), 1998, pp. 500-504
25. WEWER V; ANDERSEN LP; PAERREGAARD A; GERNOW AB; HANSEN JPH; MATZEN P; KRASILNIKOFF PA
    THE PREVALENCE AND RELATED SYMPTOMATOLOGY OF HELICOBACTER-PYLORI IN CHILDREN WITH RECURRENT ABDOMINAL-PAIN
    Acta paediatrica
    
    V. Wewer et al., "THE PREVALENCE AND RELATED SYMPTOMATOLOGY OF HELICOBACTER-PYLORI IN CHILDREN WITH RECURRENT ABDOMINAL-PAIN", Acta paediatrica, 87(8), 1998, pp. 830-835
26. OKUMURA T; SHOJI E; TAKAHASHI N; WAKEBE H; IMAGAWA K; KIKUCHI M; KOHGO Y
    DELAYED GASTRIC-EMPTYING BY HELICOBACTER-PYLORI LIPOPOLYSACCHARIDE INCONSCIOUS RATS
    Digestive diseases and sciences
    
    T. Okumura et al., "DELAYED GASTRIC-EMPTYING BY HELICOBACTER-PYLORI LIPOPOLYSACCHARIDE INCONSCIOUS RATS", Digestive diseases and sciences, 43(1), 1998, pp. 90-94
27. Sandha, GS; LeBlanc, R; Van Zanten, SJOV; Sitland, TD; Agocs, L; Burford, N; Best, L; Mahoney, D; Hoffman, P; Leddin, DJ
    Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity
    DIGESTIVE DISEASES AND SCIENCES
    
    G.S. Sandha et al., "Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity", DIG DIS SCI, 43(12), 1998, pp. 2727-2732
28. Marzio, L; Falcucci, M; Grossi, L; Ciccaglione, FA; Malatesta, MG; Castellano, A; Ballone, E
    Proximal and distal gastric distension in normal subjects and H-pylori-positive and -negative dyspeptic patients and correlation with symptoms
    DIGESTIVE DISEASES AND SCIENCES
    
    L. Marzio et al., "Proximal and distal gastric distension in normal subjects and H-pylori-positive and -negative dyspeptic patients and correlation with symptoms", DIG DIS SCI, 43(12), 1998, pp. 2757-2763
29. ODERDA G
    MANAGEMENT OF HELICOBACTER-PYLORI INFECTION IN CHILDREN
    Gut
    
    G. Oderda, "MANAGEMENT OF HELICOBACTER-PYLORI INFECTION IN CHILDREN", Gut, 43, 1998, pp. 10-13
30. LANGTRY HD; WILDE MI
    OMEPRAZOLE - A REVIEW OF ITS USE IN HELICOBACTER-PYLORI INFECTION, GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC-ULCERS INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS
    Drugs
    
    H.D. Langtry e M.I. Wilde, "OMEPRAZOLE - A REVIEW OF ITS USE IN HELICOBACTER-PYLORI INFECTION, GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC-ULCERS INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS", Drugs, 56(3), 1998, pp. 447-486
31. VAKIL N; ASHORN M
    COST-EFFECTIVENESS OF NONINVASIVE TESTING AND TREATMENT STRATEGIES FOR HELICOBACTER-PYLORI INFECTION IN CHILDREN WITH DYSPEPSIA
    The American journal of gastroenterology
    
    N. Vakil e M. Ashorn, "COST-EFFECTIVENESS OF NONINVASIVE TESTING AND TREATMENT STRATEGIES FOR HELICOBACTER-PYLORI INFECTION IN CHILDREN WITH DYSPEPSIA", The American journal of gastroenterology, 93(4), 1998, pp. 562-568
32. GISBERT JP; BOIXEDA D; DEARGILA CM
    CURRENT ROLE OF CLARITHROMYCIN IN THE ERA DICATION OF HELICOBACTER-PYLORI
    Revista espanola de enfermedades digestivas
    
    J.P. Gisbert et al., "CURRENT ROLE OF CLARITHROMYCIN IN THE ERA DICATION OF HELICOBACTER-PYLORI", Revista espanola de enfermedades digestivas, 89(4), 1997, pp. 305-312
33. BAFFONE W; BELBUSTI F; BARBIERI E; PIANETTI A; BRUSCOLINI F; FABI MT; SALVAGGIO L; ALBANO A
    COMPARISON OF COLLOIDAL BISMUTH SUBCITRATE AND METRONIDAZOLE, BOTH INCOMBINATION WITH AN H-2 ANTAGONIST AS THERAPY FOR HELICOBACTER-PYLORI
    Journal of chemotherapy
    
    W. Baffone et al., "COMPARISON OF COLLOIDAL BISMUTH SUBCITRATE AND METRONIDAZOLE, BOTH INCOMBINATION WITH AN H-2 ANTAGONIST AS THERAPY FOR HELICOBACTER-PYLORI", Journal of chemotherapy, 9(3), 1997, pp. 208-212
34. ODERDA G
    CURE OF HELICOBACTER-PYLORI IN CHILDREN
    Helicobacter
    
    G. Oderda, "CURE OF HELICOBACTER-PYLORI IN CHILDREN", Helicobacter, 2, 1997, pp. 73-76
35. LEUNG VKS; VANZANTEN SJOV
    CLINICAL PERSPECTIVE OF HELICOBACTER-PYLORI INFECTION
    Bailliere's clinical infectious diseases
    
    V.K.S. Leung e S.J.O.V. Vanzanten, "CLINICAL PERSPECTIVE OF HELICOBACTER-PYLORI INFECTION", Bailliere's clinical infectious diseases, 4(3), 1997, pp. 245-256
36. WACK RF; EATON KA; KRAMER LW
    TREATMENT OF GASTRITIS IN CHEETAHS (ACINONYX-JUBATUS)
    Journal of zoo and wildlife medicine
    
    R.F. Wack et al., "TREATMENT OF GASTRITIS IN CHEETAHS (ACINONYX-JUBATUS)", Journal of zoo and wildlife medicine, 28(3), 1997, pp. 260-266
37. GISBERT JP; BOIXEDA D; DEARGILA CM; BERMEJO F; REDONDO C; DERAFAEL L
    EROSIVE DUODENITIS - PREVALENCE OF HELICOBACTER-PYLORI INFECTION AND RESPONSE TO ERADICATION THERAPY WITH OMEPRAZOLE PLUS 2 ANTIBIOTICS
    European journal of gastroenterology & hepatology
    
    J.P. Gisbert et al., "EROSIVE DUODENITIS - PREVALENCE OF HELICOBACTER-PYLORI INFECTION AND RESPONSE TO ERADICATION THERAPY WITH OMEPRAZOLE PLUS 2 ANTIBIOTICS", European journal of gastroenterology & hepatology, 9(10), 1997, pp. 957-962
38. BLECKER U; GOLD BD
    TREATMENT OF HELICOBACTER-PYLORI INFECTION - A REVIEW
    The Pediatric infectious disease journal
    
    U. Blecker e B.D. Gold, "TREATMENT OF HELICOBACTER-PYLORI INFECTION - A REVIEW", The Pediatric infectious disease journal, 16(4), 1997, pp. 391-399
39. NEBIKI H; ARAKAWA T; HIGUCHI K; KOBAYASHI K
    QUALITY OF ULCER HEALING INFLUENCES THE RELAPSE OF GASTRIC-ULCERS IN HUMANS
    Journal of gastroenterology and hepatology
    
    H. Nebiki et al., "QUALITY OF ULCER HEALING INFLUENCES THE RELAPSE OF GASTRIC-ULCERS IN HUMANS", Journal of gastroenterology and hepatology, 12(2), 1997, pp. 109-114
40. KALACH N; BENHAMOU PH; RAYMOND J; BARBET P; BRIET F; BERGERET M; FLOURIE B; SENOUCI L; DUPONT C
    HELICOBACTER-PYLORI GASTRIC INFECTIONS IN CHILDREN
    La Presse medicale
    
    N. Kalach et al., "HELICOBACTER-PYLORI GASTRIC INFECTIONS IN CHILDREN", La Presse medicale, 26(35), 1997, pp. 1688-1694
41. ODERDA G; PONZETTO A; BOERO M; BELLIS D; FORNI M; VAIRA D; ANSALDI N
    FAMILY TREATMENT OF SYMPTOMATIC CHILDREN WITH HELICOBACTER-PYLORI INFECTION
    The Italian Journal of Gastroenterology
    
    G. Oderda et al., "FAMILY TREATMENT OF SYMPTOMATIC CHILDREN WITH HELICOBACTER-PYLORI INFECTION", The Italian Journal of Gastroenterology, 29(6), 1997, pp. 509-514
42. BARDHAN KD; SINGH S; MORRIS P; THOMPSON M; HINCHLIFFE RFC; CARY BA; WALL RM; BLAKEMORE CB
    MAINTENANCE THERAPY WITH COLLOIDAL BISMUTH SUBCITRATE REDUCES DUODENAL-ULCER RELAPSE
    The Italian Journal of Gastroenterology
    
    K.D. Bardhan et al., "MAINTENANCE THERAPY WITH COLLOIDAL BISMUTH SUBCITRATE REDUCES DUODENAL-ULCER RELAPSE", The Italian Journal of Gastroenterology, 29(2), 1997, pp. 128-134
43. PENSTON JG; MCCOLL KEL
    ERADICATION OF HELICOBACTER-PYLORI - AN OBJECTIVE ASSESSMENT OF CURRENT THERAPIES
    British journal of clinical pharmacology
    
    J.G. Penston e K.E.L. Mccoll, "ERADICATION OF HELICOBACTER-PYLORI - AN OBJECTIVE ASSESSMENT OF CURRENT THERAPIES", British journal of clinical pharmacology, 43(3), 1997, pp. 223-243
44. MIYAJI H; AZUMA T; ITO S; SUTO H; ITO Y; YAMAZAKI Y; SATO F; HIRAI M; KURIYAMA M; KATO T; KOHLI Y
    SUSCEPTIBILITY OF HELICOBACTER-PYLORI ISOLATES TO METRONIDAZOLE, CLARITHROMYCIN AND AMOXICILLIN IN-VITRO AND IN CLINICAL TREATMENT IN JAPAN
    Alimentary pharmacology & therapeutics
    
    H. Miyaji et al., "SUSCEPTIBILITY OF HELICOBACTER-PYLORI ISOLATES TO METRONIDAZOLE, CLARITHROMYCIN AND AMOXICILLIN IN-VITRO AND IN CLINICAL TREATMENT IN JAPAN", Alimentary pharmacology & therapeutics, 11(6), 1997, pp. 1131-1136
45. DEGROOT GH; DEBOTH PSM
    CISAPRIDE IN FUNCTIONAL DYSPEPSIA IN GENERAL-PRACTICE - A PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-BLIND-STUDY
    Alimentary pharmacology & therapeutics
    
    G.H. Degroot e P.S.M. Deboth, "CISAPRIDE IN FUNCTIONAL DYSPEPSIA IN GENERAL-PRACTICE - A PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-BLIND-STUDY", Alimentary pharmacology & therapeutics, 11(1), 1997, pp. 193-199
46. UNGE P
    ASSESSMENT AND SIGNIFICANCE OF HELICOBACTER-PYLORI INFECTION
    Alimentary pharmacology & therapeutics
    
    P. Unge, "ASSESSMENT AND SIGNIFICANCE OF HELICOBACTER-PYLORI INFECTION", Alimentary pharmacology & therapeutics, 11, 1997, pp. 33-39
47. MATSUMOTO S; WASHIZUKA Y; MATSUMOTO Y; TAWARA S; IKEDA F; YOKOTA Y; KARITA M
    APPEARANCE OF A METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAIN INAN INFECTED-ICR-MOUSE MODEL AND DIFFERENCE IN ERADICATION OF METRONIDAZOLE-RESISTANT AND METRONIDAZOLE-SENSITIVE STRAINS
    Antimicrobial agents and chemotherapy
    
    S. Matsumoto et al., "APPEARANCE OF A METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAIN INAN INFECTED-ICR-MOUSE MODEL AND DIFFERENCE IN ERADICATION OF METRONIDAZOLE-RESISTANT AND METRONIDAZOLE-SENSITIVE STRAINS", Antimicrobial agents and chemotherapy, 41(12), 1997, pp. 2602-2605
48. GILVARRY J; BUCKLEY MJM; BEATTIE S; HAMILTON H; OMORAIN CA
    ERADICATION OF HELICOBACTER-PYLORI AFFECTS SYMPTOMS IN NONULCER DYSPEPSIA
    Scandinavian journal of gastroenterology
    
    J. Gilvarry et al., "ERADICATION OF HELICOBACTER-PYLORI AFFECTS SYMPTOMS IN NONULCER DYSPEPSIA", Scandinavian journal of gastroenterology, 32(6), 1997, pp. 535-540
49. KATO S; TAKEYAMA J; EBINA K; NAGANUMA H
    OMEPRAZOLE-BASED DUAL AND TRIPLE REGIMENS FOR HELICOBACTER-PYLORI ERADICATION IN CHILDREN
    Pediatrics
    
    S. Kato et al., "OMEPRAZOLE-BASED DUAL AND TRIPLE REGIMENS FOR HELICOBACTER-PYLORI ERADICATION IN CHILDREN", Pediatrics, 100(1), 1997, pp. 31-35
50. GISBERT JP; BOIXEDA D; DEARGILA CM
    INFECTION BY HELICOBACTER-PYLORI - WHERE IS THE LIMIT
    Medicina Clinica
    
    J.P. Gisbert et al., "INFECTION BY HELICOBACTER-PYLORI - WHERE IS THE LIMIT", Medicina Clinica, 109(20), 1997, pp. 808-817
51. GISBERT JP; MUR M; BOIXEDA D; CENA G; DEARGILA CM; BALERIOLA IA; ABRAIRA V; PLAZA AG
    ONE-WEEK THERAPY WITH OMEPRAZOLE, CLARITH ROMYCIN AND AMOXICILLIN - HIGH EFFICACY IN ERADICATING HELICOBACTER-PYLORI AND HEALING DUODENAL-ULCER
    Medicina Clinica
    
    J.P. Gisbert et al., "ONE-WEEK THERAPY WITH OMEPRAZOLE, CLARITH ROMYCIN AND AMOXICILLIN - HIGH EFFICACY IN ERADICATING HELICOBACTER-PYLORI AND HEALING DUODENAL-ULCER", Medicina Clinica, 108(14), 1997, pp. 524-529
52. TALLEY NJ; HUNT RH
    WHAT ROLE DOES HELICOBACTER-PYLORI PLAY IN DYSPEPSIA AND NONULCER DYSPEPSIA - ARGUMENTS FOR AND AGAINST HELICOBACTER-PYLORI BEING ASSOCIATED WITH DYSPEPTIC SYMPTOMS
    Gastroenterology
    
    N.J. Talley e R.H. Hunt, "WHAT ROLE DOES HELICOBACTER-PYLORI PLAY IN DYSPEPSIA AND NONULCER DYSPEPSIA - ARGUMENTS FOR AND AGAINST HELICOBACTER-PYLORI BEING ASSOCIATED WITH DYSPEPTIC SYMPTOMS", Gastroenterology, 113(6), 1997, pp. 67-77
53. UNGE P
    WHAT OTHER REGIMENS ARE UNDER INVESTIGATION TO TREAT HELICOBACTER-PYLORI INFECTION
    Gastroenterology
    
    P. Unge, "WHAT OTHER REGIMENS ARE UNDER INVESTIGATION TO TREAT HELICOBACTER-PYLORI INFECTION", Gastroenterology, 113(6), 1997, pp. 131-148
54. TAYLOR JL; ZAGARI M; MURPHY K; FRESTON JW
    PHARMACOECONOMIC COMPARISON OF TREATMENTS FOR THE ERADICATION OF HELICOBACTER-PYLORI
    Archives of internal medicine
    
    J.L. Taylor et al., "PHARMACOECONOMIC COMPARISON OF TREATMENTS FOR THE ERADICATION OF HELICOBACTER-PYLORI", Archives of internal medicine, 157(1), 1997, pp. 87-97
55. BAYERDORFFER E; MIEHLKE S; LEHN N; MANNES GA; HOCHTER W; WEINGART J; KLANN H; SOMMER A; HELDWEIN W; HATZ R; SIMON T; BOLLE KH; BASTLEIN E; MEINING A; RUCKDESCHEL G; STOLTE M
    CURE OF GASTRIC-ULCER DISEASE AFTER CURE OF HELICOBACTER-PYLORI INFECTION - GERMAN GASTRIC-ULCER STUDY
    European journal of gastroenterology & hepatology
    
    E. Bayerdorffer et al., "CURE OF GASTRIC-ULCER DISEASE AFTER CURE OF HELICOBACTER-PYLORI INFECTION - GERMAN GASTRIC-ULCER STUDY", European journal of gastroenterology & hepatology, 8(4), 1996, pp. 343-349
56. DELTENRE M; DEKOSTER E; CAUCHETEUR B; OTERO J; JONAS C
    THE ERADICATION OF HELICOBACTER-PYLORI IN 1995 - A CRITICAL-REVIEW OFAVAILABLE TREATMENTS
    Gastroenterologie clinique et biologique
    
    M. Deltenre et al., "THE ERADICATION OF HELICOBACTER-PYLORI IN 1995 - A CRITICAL-REVIEW OFAVAILABLE TREATMENTS", Gastroenterologie clinique et biologique, 20(1BIS), 1996, pp. 44-52
57. VARANNES SDB; SCARPIGNATO C
    RELATIONSHIPS BETWEEN HELICOBACTER-PYLORI -ASSOCIATED GASTRITIS AND DYSPEPTIC SYMPTOMS
    Gastroenterologie clinique et biologique
    
    S.D.B. Varannes e C. Scarpignato, "RELATIONSHIPS BETWEEN HELICOBACTER-PYLORI -ASSOCIATED GASTRITIS AND DYSPEPTIC SYMPTOMS", Gastroenterologie clinique et biologique, 20(1BIS), 1996, pp. 84-94
58. BOUCHE O
    SHOULD HELICOBACTER-PYLORI BE ERADICATED IN A PATIENT WITH CHRONIC GASTRITIS
    Gastroenterologie clinique et biologique
    
    O. Bouche, "SHOULD HELICOBACTER-PYLORI BE ERADICATED IN A PATIENT WITH CHRONIC GASTRITIS", Gastroenterologie clinique et biologique, 20(1BIS), 1996, pp. 143-153
59. CUCCHIARA S; SALVIA G; AZZEQEH N; DARMIENTO F; DEPETRA MR; RAPAGIOLO S; CAMPANOZZI A; EMILIANO M
    HELICOBACTER-PYLORI GASTRITIS AND NONULCER DYSPEPSIA IN CHILDHOOD - EFFICACY OF ONE-WEEK TRIPLE ANTIMICROBIAL THERAPY IN ERADICATING THE ORGANISM
    The Italian Journal of Gastroenterology
    
    S. Cucchiara et al., "HELICOBACTER-PYLORI GASTRITIS AND NONULCER DYSPEPSIA IN CHILDHOOD - EFFICACY OF ONE-WEEK TRIPLE ANTIMICROBIAL THERAPY IN ERADICATING THE ORGANISM", The Italian Journal of Gastroenterology, 28(8), 1996, pp. 430-435
60. LAHEIJ RJF; JANSEN JBMJ; VANDELISDONK EH; VERBEEK ALM
    REVIEW ARTICLE - SYMPTOM IMPROVEMENT THROUGH ERADICATION OF HELICOBACTER-PYLORI IN PATIENTS WITH NONULCER DYSPEPSIA
    Alimentary pharmacology & therapeutics
    
    R.J.F. Laheij et al., "REVIEW ARTICLE - SYMPTOM IMPROVEMENT THROUGH ERADICATION OF HELICOBACTER-PYLORI IN PATIENTS WITH NONULCER DYSPEPSIA", Alimentary pharmacology & therapeutics, 10(6), 1996, pp. 843-850
61. CIOCIOLA AA; WEBB DD; HEATH A; WALSH JH
    EFFECTS OF RANITIDINE BISMUTH CITRATE ON GASTRIC-ACID SECRETION AND GASTRIN-RELEASE IN SUBJECTS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION
    Alimentary pharmacology & therapeutics
    
    A.A. Ciociola et al., "EFFECTS OF RANITIDINE BISMUTH CITRATE ON GASTRIC-ACID SECRETION AND GASTRIN-RELEASE IN SUBJECTS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION", Alimentary pharmacology & therapeutics, 10(6), 1996, pp. 905-912
62. PENSTON JG
    REVIEW ARTICLE - CLINICAL ASPECTS OF HELICOBACTER-PYLORI ERADICATION THERAPY IN PEPTIC-ULCER DISEASE
    Alimentary pharmacology & therapeutics
    
    J.G. Penston, "REVIEW ARTICLE - CLINICAL ASPECTS OF HELICOBACTER-PYLORI ERADICATION THERAPY IN PEPTIC-ULCER DISEASE", Alimentary pharmacology & therapeutics, 10(4), 1996, pp. 469-486
63. LAZZARONI M; BARGIGGIA S; SANGALETTI O; MACONI G; BOLDORINI M; PORRO GB
    ERADICATION OF HELICOBACTER-PYLORI AND LONG-TERM OUTCOME OF FUNCTIONAL DYSPEPSIA - A CLINICAL ENDOSCOPIC STUDY
    Digestive diseases and sciences
    
    M. Lazzaroni et al., "ERADICATION OF HELICOBACTER-PYLORI AND LONG-TERM OUTCOME OF FUNCTIONAL DYSPEPSIA - A CLINICAL ENDOSCOPIC STUDY", Digestive diseases and sciences, 41(8), 1996, pp. 1589-1594
64. DIMARIO F; BATTAGLIA G; LEANDRO G; GRASSO G; VIANELLO F; VIGNERI S
    SHORT-TERM TREATMENT OF GASTRIC-ULCER - A META-ANALYTICAL EVALUATION OF BLIND TRIALS
    Digestive diseases and sciences
    
    F. Dimario et al., "SHORT-TERM TREATMENT OF GASTRIC-ULCER - A META-ANALYTICAL EVALUATION OF BLIND TRIALS", Digestive diseases and sciences, 41(6), 1996, pp. 1108-1131
65. HOOKNIKANNE J; AHO P; KARKKAINEN P; KOSUNEN TU; SALASPURO M
    THE HELICOBACTER-FELIS MOUSE MODEL IN ASSESSING ANTI-HELICOBACTER THERAPIES AND GASTRIC-MUCOSAL PROSTAGLANDIN E(2) LEVELS
    Scandinavian journal of gastroenterology
    
    J. Hooknikanne et al., "THE HELICOBACTER-FELIS MOUSE MODEL IN ASSESSING ANTI-HELICOBACTER THERAPIES AND GASTRIC-MUCOSAL PROSTAGLANDIN E(2) LEVELS", Scandinavian journal of gastroenterology, 31(4), 1996, pp. 334-338
66. TALLEY NJ
    HELICOBACTER-PYLORI AND NONULCER DYSPEPSIA
    Scandinavian journal of gastroenterology
    
    N.J. Talley, "HELICOBACTER-PYLORI AND NONULCER DYSPEPSIA", Scandinavian journal of gastroenterology, 31, 1996, pp. 19-22
67. UNGE P; BERSTAD A
    POOLED ANALYSIS OF ANTI-HELICOBACTER PYLORI TREATMENT REGIMENS
    Scandinavian journal of gastroenterology
    
    P. Unge e A. Berstad, "POOLED ANALYSIS OF ANTI-HELICOBACTER PYLORI TREATMENT REGIMENS", Scandinavian journal of gastroenterology, 31, 1996, pp. 27-40
68. CIOCIOLA AA; WEBB DD; TURNER K
    DUAL AND TRIPLE THERAPY REGIMENS OF ANTISECRETORY AGENTS AND ANTIBIOTICS FOR THE ERADICATION OF HELICOBACTER-PYLORI - AN OVERVIEW
    Scandinavian journal of gastroenterology
    
    A.A. Ciociola et al., "DUAL AND TRIPLE THERAPY REGIMENS OF ANTISECRETORY AGENTS AND ANTIBIOTICS FOR THE ERADICATION OF HELICOBACTER-PYLORI - AN OVERVIEW", Scandinavian journal of gastroenterology, 31, 1996, pp. 3-9
69. ARMSTRONG D
    HELICOBACTER-PYLORI INFECTION AND DYSPEPSIA
    Scandinavian journal of gastroenterology
    
    D. Armstrong, "HELICOBACTER-PYLORI INFECTION AND DYSPEPSIA", Scandinavian journal of gastroenterology, 31, 1996, pp. 38-47
70. UNGE P
    REVIEW OF HELICOBACTER-PYLORI ERADICATION REGIMENS
    Scandinavian journal of gastroenterology
    
    P. Unge, "REVIEW OF HELICOBACTER-PYLORI ERADICATION REGIMENS", Scandinavian journal of gastroenterology, 31, 1996, pp. 74-81
71. BUJANOVER Y; REIF S; YAHAV J
    HELICOBACTER-PYLORI AND PEPTIC DISEASE IN THE PEDIATRIC-PATIENT
    The Pediatric clinics of North America
    
    Y. Bujanover et al., "HELICOBACTER-PYLORI AND PEPTIC DISEASE IN THE PEDIATRIC-PATIENT", The Pediatric clinics of North America, 43(1), 1996, pp. 213-234
72. GISBERT JP; BOIXEDA D; DEARGILA CM; PLAZA AG
    WHY, WHEN AND HOW TO TREAT HELICOBACTER-P YLORI INFECTION IN GASTRODUODENAL ULCER DISEASE
    Revista Clinica Espanola
    
    J.P. Gisbert et al., "WHY, WHEN AND HOW TO TREAT HELICOBACTER-P YLORI INFECTION IN GASTRODUODENAL ULCER DISEASE", Revista Clinica Espanola, 196(9), 1996, pp. 610-621
73. PHILLIPS M
    HELICOBACTER-PYLORI, DYSPEPSIA, AND UREA BREATH TESTS - RESPONSE
    The American journal of gastroenterology
    
    M. Phillips, "HELICOBACTER-PYLORI, DYSPEPSIA, AND UREA BREATH TESTS - RESPONSE", The American journal of gastroenterology, 91(7), 1996, pp. 1468-1469
74. VANZANTEN SJOV; CLEARY C; TALLEY NJ; PETERSON TC; NYREN O; BRADLEY LA; VERLINDEN M; TYTGAT GNJ
    DRUG-TREATMENT OF FUNCTIONAL DYSPEPSIA - A SYSTEMATIC ANALYSIS OF TRIAL METHODOLOGY WITH RECOMMENDATIONS FOR DESIGN OF FUTURE TRIALS
    The American journal of gastroenterology
    
    S.J.O.V. Vanzanten et al., "DRUG-TREATMENT OF FUNCTIONAL DYSPEPSIA - A SYSTEMATIC ANALYSIS OF TRIAL METHODOLOGY WITH RECOMMENDATIONS FOR DESIGN OF FUTURE TRIALS", The American journal of gastroenterology, 91(4), 1996, pp. 660-673
75. TREIBER G
    THE INFLUENCE OF DRUG-DOSAGE ON HELICOBACTER-PYLORI ERADICATION - A COST-EFFECTIVENESS ANALYSIS
    The American journal of gastroenterology
    
    G. Treiber, "THE INFLUENCE OF DRUG-DOSAGE ON HELICOBACTER-PYLORI ERADICATION - A COST-EFFECTIVENESS ANALYSIS", The American journal of gastroenterology, 91(2), 1996, pp. 246-257
76. THIJS JC; KUIPERS EJ; VANZWET AA; PENA AS; DEGRAAFF J
    TREATMENT OF HELICOBACTER-PYLORI INFECTIONS
    Quarterly Journal of Medicine
    
    J.C. Thijs et al., "TREATMENT OF HELICOBACTER-PYLORI INFECTIONS", Quarterly Journal of Medicine, 88(6), 1995, pp. 369-389
77. NOACH LA; EEKHOF JLA; BOUR LJ; MEYJES FEP; TYTGAT GNJ; DEVISSER BWO
    BISMUTH SALTS AND NEUROTOXICITY - A RANDOMIZED, SINGLE-BLIND AND CONTROLLED-STUDY
    Human & experimental toxicology
    
    L.A. Noach et al., "BISMUTH SALTS AND NEUROTOXICITY - A RANDOMIZED, SINGLE-BLIND AND CONTROLLED-STUDY", Human & experimental toxicology, 14(4), 1995, pp. 349-355
78. PORRO GB; PARENTE F
    NATURE OF NONULCER DYSPEPSIA AND RELATED CONDITIONS
    Bailliere's clinical gastroenterology
    
    G.B. Porro e F. Parente, "NATURE OF NONULCER DYSPEPSIA AND RELATED CONDITIONS", Bailliere's clinical gastroenterology, 9(3), 1995, pp. 549-562
79. HARRIS AW; MISIEWICZ JJ
    ERADICATION OF HELICOBACTER-PYLORI
    Bailliere's clinical gastroenterology
    
    A.W. Harris e J.J. Misiewicz, "ERADICATION OF HELICOBACTER-PYLORI", Bailliere's clinical gastroenterology, 9(3), 1995, pp. 583-613
80. THOMPSON WG
    DYSPEPSIA - IS A TRIAL OF THERAPY APPROPRIATE
    CMAJ. Canadian Medical Association journal
    
    W.G. Thompson, "DYSPEPSIA - IS A TRIAL OF THERAPY APPROPRIATE", CMAJ. Canadian Medical Association journal, 153(3), 1995, pp. 293-299
81. CHEN TS; TSAY SH; CHANG FY; LEE SD
    TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI AND REDUCTION OF DUODENAL-ULCER RELAPSE - COMPARISON OF 1-WEEK AND 2-WEEK REGIMENS AND RECRUDESCENCE RATES OVER 12 MONTHS
    Journal of gastroenterology and hepatology
    
    T.S. Chen et al., "TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI AND REDUCTION OF DUODENAL-ULCER RELAPSE - COMPARISON OF 1-WEEK AND 2-WEEK REGIMENS AND RECRUDESCENCE RATES OVER 12 MONTHS", Journal of gastroenterology and hepatology, 10(3), 1995, pp. 300-305
82. ROINE RP; SALMELA KS; SALASPURO M
    ALCOHOL METABOLISM IN HELICOBACTER PYLORI-INFECTED STOMACH
    Annals of medicine
    
    R.P. Roine et al., "ALCOHOL METABOLISM IN HELICOBACTER PYLORI-INFECTED STOMACH", Annals of medicine, 27(5), 1995, pp. 583-588
83. MASCI E; COLOMBO E; TESTONI PA; FANTI L; GUSLANDI M; TITTOBELLO A
    COLLOID BISMUTH VERSUS FAMOTIDINE IN THE TREATMENT AND PREVENTION OF DUODENAL-ULCER RELAPSE - RESULTS OF A DOUBLE-BLIND, DOUBLE DUMMY RANDOMIZED STUDY
    Fundamental and clinical pharmacology
    
    E. Masci et al., "COLLOID BISMUTH VERSUS FAMOTIDINE IN THE TREATMENT AND PREVENTION OF DUODENAL-ULCER RELAPSE - RESULTS OF A DOUBLE-BLIND, DOUBLE DUMMY RANDOMIZED STUDY", Fundamental and clinical pharmacology, 9(3), 1995, pp. 280-283
84. BURETTE A; GLUPCZYNSKI Y
    HELICOBACTER-PYLORI - THE PLACE OF THE NEW MACROLIDES IN THE ERADICATION OF THE BACTERIA IN PEPTIC-ULCER DISEASE
    Infection
    
    A. Burette e Y. Glupczynski, "HELICOBACTER-PYLORI - THE PLACE OF THE NEW MACROLIDES IN THE ERADICATION OF THE BACTERIA IN PEPTIC-ULCER DISEASE", Infection, 23, 1995, pp. 44-52
85. WITTEMAN EM; TYTGAT GNJ
    FUNCTIONAL DYSPEPSIA
    Netherlands journal of medicine
    
    E.M. Witteman e G.N.J. Tytgat, "FUNCTIONAL DYSPEPSIA", Netherlands journal of medicine, 46(4), 1995, pp. 205-211
86. TALLEY NJ
    REVIEW ARTICLE - FUNCTIONAL DYSPEPSIA - SHOULD TREATMENT BE TARGETED ON DISTURBED PHYSIOLOGY
    Alimentary pharmacology & therapeutics
    
    N.J. Talley, "REVIEW ARTICLE - FUNCTIONAL DYSPEPSIA - SHOULD TREATMENT BE TARGETED ON DISTURBED PHYSIOLOGY", Alimentary pharmacology & therapeutics, 9(2), 1995, pp. 107-115
87. BUCKLEY M; OMORAIN C
    PREVALENCE OF HELICOBACTER-PYLORI IN NONULCER DYSPEPSIA
    Alimentary pharmacology & therapeutics
    
    M. Buckley e C. Omorain, "PREVALENCE OF HELICOBACTER-PYLORI IN NONULCER DYSPEPSIA", Alimentary pharmacology & therapeutics, 9, 1995, pp. 53-58
88. CHING CK; LAM SK
    NONULCER DYSPEPSIA - ASSOCIATION WITH CHRONIC HELICOBACTER-PYLORI INFECTION-RELATED GASTRITIS
    Journal of clinical gastroenterology
    
    C.K. Ching e S.K. Lam, "NONULCER DYSPEPSIA - ASSOCIATION WITH CHRONIC HELICOBACTER-PYLORI INFECTION-RELATED GASTRITIS", Journal of clinical gastroenterology, 21, 1995, pp. 140-145
89. VANZWET AA; THIJS JC; DEGRAAF B
    EXPLANATIONS FOR HIGH-RATES OF ERADICATION WITH TRIPLE THERAPY USING METRONIDAZOLE IN PATIENTS HARBORING METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAINS
    Antimicrobial agents and chemotherapy
    
    A.A. Vanzwet et al., "EXPLANATIONS FOR HIGH-RATES OF ERADICATION WITH TRIPLE THERAPY USING METRONIDAZOLE IN PATIENTS HARBORING METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAINS", Antimicrobial agents and chemotherapy, 39(1), 1995, pp. 250-252
90. PEREIRALIMA JG; SCHOLL JG; PINHEIRO J; PEREIRALIMA JB; RIEMANN JF
    HELICOBACTER-PYLORI-ASSOCIATED GASTRITIS - DOES IT PLAY A ROLE IN FUNCTIONAL DYSPEPSIA
    Zeitschrift fur Gastroenterologie
    
    J.G. Pereiralima et al., "HELICOBACTER-PYLORI-ASSOCIATED GASTRITIS - DOES IT PLAY A ROLE IN FUNCTIONAL DYSPEPSIA", Zeitschrift fur Gastroenterologie, 33(8), 1995, pp. 421-425
91. CABALLEROPLASENCIA AM; MUROSNAVARRO MC; MARTINRUIZ JL; VALENZUELABARRANCO M; REYESGARCIA MCDL; CASADOCABALLERO FJ; RODRIGUEZTELLEZ M; LOPEZMANAS JG
    DYSPEPTIC SYMPTOMS AND GASTRIC-EMPTYING OF SOLIDS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA - ROLE OF HELICOBACTER-PYLORI INFECTION
    Scandinavian journal of gastroenterology
    
    A.M. Caballeroplasencia et al., "DYSPEPTIC SYMPTOMS AND GASTRIC-EMPTYING OF SOLIDS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA - ROLE OF HELICOBACTER-PYLORI INFECTION", Scandinavian journal of gastroenterology, 30(8), 1995, pp. 745-751
92. GOTZ JM; VEENENDAAL RA; VESELIC M; BERNARDS S; LAMERS CBHW
    TRIPLE THERAPY WITH RANITIDINE, CLARITHROMYCIN, AND METRONIDAZOLE IN THE TREATMENT OF HELICOBACTER-PYLORI
    Scandinavian journal of gastroenterology
    
    J.M. Gotz et al., "TRIPLE THERAPY WITH RANITIDINE, CLARITHROMYCIN, AND METRONIDAZOLE IN THE TREATMENT OF HELICOBACTER-PYLORI", Scandinavian journal of gastroenterology, 30, 1995, pp. 34-37
93. DIXON JS
    HELICOBACTER-PYLORI ERADICATION - UNRAVELING THE FACTS
    Scandinavian journal of gastroenterology
    
    J.S. Dixon, "HELICOBACTER-PYLORI ERADICATION - UNRAVELING THE FACTS", Scandinavian journal of gastroenterology, 30, 1995, pp. 48-62
94. MEARIN F; DERIBOT X; BALBOA A; SALAS A; VARAS MJ; CUCALA M; BARTOLOME R; ARMENGOL JR; MALAGELADA JR
    DOES HELICOBACTER-PYLORI INFECTION INCREASE GASTRIC SENSITIVITY IN FUNCTIONAL DYSPEPSIA
    Gut
    
    F. Mearin et al., "DOES HELICOBACTER-PYLORI INFECTION INCREASE GASTRIC SENSITIVITY IN FUNCTIONAL DYSPEPSIA", Gut, 37(1), 1995, pp. 47-51
95. RAUWS EAJ; VANDERHULST RWM
    CURRENT GUIDELINES FOR THE ERADICATION OF HELICOBACTER-PYLORI IN PEPTIC-ULCER DISEASE
    Drugs
    
    E.A.J. Rauws e R.W.M. Vanderhulst, "CURRENT GUIDELINES FOR THE ERADICATION OF HELICOBACTER-PYLORI IN PEPTIC-ULCER DISEASE", Drugs, 50(6), 1995, pp. 984-990
96. SCHLEMPER RJ; VANDERWERF SDJ; VANDENBROUCKE JP; BIEMOND I; LAMERS CBHW
    NONULCER DYSPEPSIA IN A DUTCH WORKING POPULATION AND HELICOBACTER-PYLORI - ULCER HISTORY AS AN EXPLANATION OF AN APPARENT ASSOCIATION
    Archives of internal medicine
    
    R.J. Schlemper et al., "NONULCER DYSPEPSIA IN A DUTCH WORKING POPULATION AND HELICOBACTER-PYLORI - ULCER HISTORY AS AN EXPLANATION OF AN APPARENT ASSOCIATION", Archives of internal medicine, 155(1), 1995, pp. 82-87
97. ELTA GH; SCHEIMAN JM; BARNETT JL; NOSTRANT TT; BEHLER EM; CRAUSE I; APPELMAN HD
    LONG-TERM FOLLOW-UP OF HELICOBACTER-PYLORI TREATMENT IN NONULCER DYSPEPSIA PATIENTS
    The American journal of gastroenterology
    
    G.H. Elta et al., "LONG-TERM FOLLOW-UP OF HELICOBACTER-PYLORI TREATMENT IN NONULCER DYSPEPSIA PATIENTS", The American journal of gastroenterology, 90(7), 1995, pp. 1089-1093
98. NOACH LA; BERTOLA MA; SCHWARTZ MP; RAUWS EAJ; TYTGAT GNJ
    TREATMENT OF HELICOBACTER-PYLORI INFECTION - AN EVALUATION OF VARIOUSTHERAPEUTIC TRIALS
    European journal of gastroenterology & hepatology
    
    L.A. Noach et al., "TREATMENT OF HELICOBACTER-PYLORI INFECTION - AN EVALUATION OF VARIOUSTHERAPEUTIC TRIALS", European journal of gastroenterology & hepatology, 6(7), 1994, pp. 585-591
99. WITTEMAN E; BECX M; JANSSEN A; DEKONING R; VOLLAARD E
    THE INFLUENCE OF COLLOIDAL BISMUTH SUBCITRATE ON FECAL AEROBES
    Microbial ecology in health and disease
    
    E. Witteman et al., "THE INFLUENCE OF COLLOIDAL BISMUTH SUBCITRATE ON FECAL AEROBES", Microbial ecology in health and disease, 7(4), 1994, pp. 229-231
100. VANZANTEN SJOV; SHERMAN PM
     INDICATIONS FOR TREATMENT OF HELICOBACTER-PYLORI INFECTION - A SYSTEMATIC OVERVIEW
     CMAJ. Canadian Medical Association journal
     
     S.J.O.V. Vanzanten e P.M. Sherman, "INDICATIONS FOR TREATMENT OF HELICOBACTER-PYLORI INFECTION - A SYSTEMATIC OVERVIEW", CMAJ. Canadian Medical Association journal, 150(2), 1994, pp. 189-198